biguanides has been researched along with exenatide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scemons, D | 1 |
Hall, MA | 1 |
Abiru, N; Ando, T; Fujishima, K; Haraguchi, A; Imaizumi, M; Kawakami, A; Matsumoto, K; Mori, F; Takamura, N; Yamasaki, H | 1 |
Ip, W; Kirchhof, MG | 1 |
3 review(s) available for biguanides and exenatide
Article | Year |
---|---|
Are you up-to-date on diabetes medications?
Topics: Amyloid; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Monitoring; Exenatide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Patient Selection; Peptides; Sulfonylurea Compounds; Thiazolidinediones; Venoms | 2007 |
Type 2 diabetes: the many facets of care.
Topics: Adult; Amyloid; Biguanides; Community Health Nursing; Diabetes Mellitus, Type 2; Diabetic Foot; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Home Care Services; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Life Style; Male; Patient Education as Topic; Peptides; Sulfonylurea Compounds; Thiazolidinediones; Venoms; Wound Healing | 2008 |
Glycemic Control in the Treatment of Psoriasis.
Topics: Biguanides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Liraglutide; Peptides; Psoriasis; Thiazolidinediones; Venoms | 2017 |
1 other study(ies) available for biguanides and exenatide
Article | Year |
---|---|
Multiple drug combination of anti-diabetic agents as a predictor for poor clinical response to liraglutide.
Topics: Adult; Aged; Alanine Transaminase; Anthropometry; Biguanides; Body Weight; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Liraglutide; Male; Middle Aged; Peptides; Prognosis; Retrospective Studies; Sulfonylurea Compounds; Thiazolidines; Treatment Outcome; Venoms | 2014 |